Strong in the pharmaceutical market through industry specific CRM
Complex business relationships and enhanced sales structures cause rapid market change in the medical industry. Strong customer loyalty and a targeted marketing and sales organisation get more and more important. Industry-specific Customer Relationship Management (CRM) supports you specifically with these challenges.
With the system CRM update.seven you meet the change in target groups and the conditions of competition in the Healthcare industry with an efficient management of your customer relationships. Behind this stands the continuous integration and central control of all relevant information and processes. You gain a comprehensive picture of each of your target groups. This allows you a differentiated realization of your marketing strategy. At the same time, your sales representatives can focus on the most potential customers.
Application areas for update.seven
- Pharma ethisch
- OTC/Consumer Health
- Generic drugs
- Medical Technology
- Biotechnology
Comprehensive industry orientation
The CRM solution covers the requirements of various segments of the health sector: with this, especially the dynamic market for generic drugs benefits of always up-to-date and transparent competition data. In the field of OTC and consumer Health, sales actions like direct business or behind-the-counter area are supported effectively. For the sector pharma etisch with its huge range of doctor profiles, differentiated marketing strategies can be mapped flexibly. And medical technology and biotechnology companies have a tight hold on even the most complex structures of the customer business.

Hight investment protection
Our experienced specialists will implement your pharmaceutical-specific CRM solution fast and cost-effectively. Technological progress is secured for the future, too. This is granted by the releaseability of the solution for the standard of update.seven and the continuous further development by update software AG. Especially for this, the Competence Center “Life Sciences International” has been founded. Additional investment protection is granted from the producer with the strong market position and the prevalence of the solution with approximately 2,000 installations.






